Target intelligence / Profile preview

RNA, U6 small nuclear 280, pseudogene (RNU6-280P)

Target
RNU6-280P
Molecular classification
Other (classified as a *pseudogene* of a non-coding small nuclear RNA, not a protein, enzyme, receptor, or transcription factor)
01

Overview

RNA, U6 small nuclear 280, pseudogene (RNU6-280P) is a *pseudogene*—a non-functional genomic DNA segment—related to the U6 family of small nuclear RNAs (snRNAs)[1][5]. U6 snRNAs are non-coding RNAs that serve an essential role in the spliceosome complex, which catalyzes the removal of introns from pre-mRNA during RNA splicing; however, RNU6-280P lacks the ability to be expressed as a functional snRNA or to assemble into spliceosomal complexes[3][4][5]. Many pseudogenes for U6 snRNA exist in the human genome, reflecting the evolutionary importance and repetitive nature of this gene family. RNU6-280P is not considered a protein, enzyme, receptor, or therapeutic target and does not have direct functional, disease, or pharmacological relevance[1][5]. Summary of application: RNU6-280P is a non-coding RNA pseudogene, included in genome annotations for reference but not as a functional gene, disease gene, or drug target. It is most relevant for genome studies and bioinformatics, not for therapeutic or diagnostic intervention.

Other names
RNU6-1221PRNA, U6 small nuclear 1221, pseudogene
02

Biological functions

Other (does not encode a functional molecule; no known direct role in biological function; parent molecule involved in RNA splicing machinery)
03

Disease associations

Other (no direct established role; not associated with specific diseases; not used as a biomarker, gene product, or disease gene)

Beyond the preview

Go deeper on RNA, U6 small nuclear 280, pseudogene (RNU6-280P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 280, pseudogene (RNU6-280P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call